Public notice and comment on new members of the Global Validation Advisory Committee (GVAC)

High-level resource mobilization conference to eliminate viral hepatitis

WHO announces the update of hepatitis B guidelines on testing and treatment

New WHO study: Making diagnosis of hepatitis C more accessible and closer to the community using point-of-care HCV viral load assays

WHO position paper on hepatitis A vaccines published

WHO publishes new guidelines on HIV, hepatitis and STIs for key populations

WHO and UNAIDS support countries to introduce virtual interventions and HIV self-testing

WHO and ANRS Emerging Infectious Diseases strengthen their collaboration in the area of HIV, viral hepatitis and sexually transmitted infections

WHO publishes updated guidance on hepatitis C infection – with new recommendations on treatment of adolescents and children, simplified service delivery and diagnostics

World Hepatitis Summit 2022 statement

World Hepatitis Summit 2022 urges action to eliminate viral hepatitis as unexplained hepatitis cases in children rise globally

Seventy-fifth World Health Assembly noted the 2022-2030 Global Health Sector Strategy on HIV, hepatitis and STIs

SAGE April 2022 meeting highlights

Zero Discrimination Day, 1 March 2022

Public notice and comment on new members of the Global Validation Advisory Committee (GVAC)

WHO publishes updated guidance on validation of elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus

SAGE October 2021 meeting highlights

WHO announces the update of HCV guidelines on testing and treatment

Public notice and comment on new Global Validation Advisory Committee (GVAC) members

“Hepatitis can’t wait” - WHO commemorates World Hepatitis Day 2021